Marker Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRKR and other ETFs, options, and stocks.About MRKR
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
CEOJuan F. Vera
CEOJuan F. Vera
Employees5
Employees5
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded1991
Founded1991
Employees5
Employees5
MRKR Key Statistics
Market cap24.34M
Market cap24.34M
Price-Earnings ratio-1.18
Price-Earnings ratio-1.18
Dividend yield—
Dividend yield—
Average volume342.56K
Average volume342.56K
High today$1.47
High today$1.47
Low today$1.46
Low today$1.46
Open price$1.45
Open price$1.45
Volume1.81K
Volume1.81K
52 Week high$5.95
52 Week high$5.95
52 Week low$0.8099
52 Week low$0.8099
Stock Snapshot
As of today, Marker Therapeutics(MRKR) shares are valued at $1.46. The company's market cap stands at 24.34M, with a P/E ratio of -1.18.
On 2025-12-11, Marker Therapeutics(MRKR) stock traded between a low of $1.46 and a high of $1.47. Shares are currently priced at $1.46, which is 0.0% above the low and -0.7% below the high.
The Marker Therapeutics(MRKR)'s current trading volume is 1.81K, compared to an average daily volume of 342.56K.
In the last year, Marker Therapeutics(MRKR) shares hit a 52-week high of $5.95 and a 52-week low of $0.81.
In the last year, Marker Therapeutics(MRKR) shares hit a 52-week high of $5.95 and a 52-week low of $0.81.
People also own
Based on the portfolios of people who own MRKR. This list is generated using Robinhood data, and it’s not a recommendation.